Some gangliosides, such as GM3 and GM2, inhibited cell motility facilitated by the tetraspanins CD9 and CD82 in some tumor cell lines (for example, colorectal, haptotactic, and bladder cancer cells) [42-45]. This evidence concerns the gene CD9 and urinary bladder carcinoma.